0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Adriana Feder, MD; Michael K. Parides, PhD; James W. Murrough, MD; et al.
JAMA Psychiatry. 2014;71(6):681-688. doi:10.1001/jamapsychiatry.2014.62.
Includes: CME, Supplemental Content

Viewpoint | 
Ian R. H. Rockett, PhD, MPH; Nestor D. Kapusta, MD; Jeffrey H. Coben, MD
JAMA Psychiatry. 2014;71(3):231-232. doi:10.1001/jamapsychiatry.2013.3738.

Original Investigation | 
Hsien-Yuan Lane, MD, PhD; Ching-Hua Lin, MD, PhD; Michael F. Green, PhD; et al.
JAMA Psychiatry. 2013;70(12):1267-1275. doi:10.1001/jamapsychiatry.2013.2159.

Original Article |  FREE
Eugene C. Somoza, MD, PhD; Douglas Winship, BS; Charles W. Gorodetzky, MD, PhD; et al.
JAMA Psychiatry. 2013;70(6):630-637. doi:10.1001/jamapsychiatry.2013.872.
Includes: Supplemental Content

Original Article |  FREE
Mark Olfson, MD, MPH; Carlos Blanco, MD, PhD; Shang-Min Liu, MS; et al.
Arch Gen Psychiatry. 2012;69(12):1247-1256. doi:10.1001/archgenpsychiatry.2012.647.
Includes: Supplemental Content

Original Article |  FREE
Steven E. Arnold, MD; Li-Ying Han, MS; Paul J. Moberg, PhD; et al.
Arch Gen Psychiatry. 2001;58(9):829-835. doi:10.1001/archpsyc.58.9.829.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Annette Langer-Gould, MD, PhD; Lei Qian, PhD; Sara Y. Tartof, PhD; et al.
JAMA Ophthalmology
Brief Report  | 
Risk for Uveitis With Oral Moxifloxacin:  A Comparative Safety Study
Brennan Eadie, MD, PhD; Mahyar Etminan, PharmD, MSc; Frederick S. Mikelberg, MD, FRCSC
JAMA Ophthalmology
Invited Commentary  | 
We Need to Be Better Prepared for Hydroxychloroquine Retinopathy
Hendrik P. N. Scholl, MD, MA; Syed Mahmood Ali Shah, MBBS
JAMA Ophthalmology
Original Investigation  | 
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles, MD; Michael F. Marmor, MD